Hospitals | June 03, 2026
CARE Hospitals strengthens advanced cardiac care
The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries
The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries
A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India
The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials
Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices
An exploratory overall survival signal also leaned in favor of the combination, though the companies noted the result remains preliminary
The safety profile was described as manageable, though not without notable toxicities
The trial results are for the pharma powerhouse's RET-targeted therapy Retevmo (selpercatinib)
The accepted studies span several critical areas of oncology, including nutrition, genomics, precision medicine, patient-reported outcomes, and community-based cancer care
While overall survival data remain immature, the results pointed to a favourable trend.
Approved as a web-based pre-diagnostic tool for suspected rare diseases and classified as a Class A (non-sterile and non-measuring) medical device
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
